Publications by authors named "G Moi"
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort.
Biomedicines
October 2024
: Out of 39.9 million adults living with HIV in 2022, 20 million were women. Despite bearing a significant burden, women remain underrepresented in clinical trials, including those for antiretroviral treatments (ART).
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates ChatGPT's potential in providing accurate and inclusive information on HIV prevention through an assessment conducted by a diverse team of medical professionals and community experts.
- Results showed that ChatGPT had high accuracy (median score of 5.5/6) and completeness (median score of 3/3), but inclusivity scores (median of 2/3) revealed some outdated terminology and underrepresentation of certain communities.
- While ChatGPT performs well in delivering scientifically accurate information, it needs improvement in socio-political context and inclusivity to enhance health communication effectiveness.
Article Synopsis
- A new prognostic model for COVID-19 progression was developed to include vaccination status and early treatment, which were missing from previous scores.
- The study analyzed data from 1,145 patients in Sassari, revealing that older age, comorbidities, and lack of vaccination were linked to disease progression, where 29.3% of patients required supplemental oxygen.
- Multivariate analysis identified key risk factors for progression and created an easy-to-use scoring system based on various clinical and demographic variables, enhancing the ability to predict patient outcomes.
Clinical trials demonstrated the role of vaccines and antiviral treatments against SARS-CoV-2 in reducing the likelihood of disease progression and death. However, there are limited data available regarding the time to negativity of people who received these treatments. Further, several comorbidities and risk factors might affect the impact of vaccines and antiviral treatments.
View Article and Find Full Text PDFAfter 40 years of its appearance, human immunodeficiency virus (HIV) infection remains a leading public health challenge worldwide. Since the introduction of antiretroviral treatment (ART), HIV infection has become a chronic condition, and people living with HIV could have life expectancies close to those of the general population. People with HIV often have an increased risk of infection or experience more severe morbidity following exposure to vaccine-preventable diseases.
View Article and Find Full Text PDF